- Home
- ATON vs PULM Comparison
ATON vs PULM Comparison
Compare ATON & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATON | PULM |
|---|---|---|
| Founded | 1973 | 2003 |
| Country | British Virgin Islands | United States |
| Employees | 4 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 9.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ATON | PULM |
|---|---|---|
| Price | $0.33 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 763.1K | 49.8K |
| Earning Date | 07-24-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,910,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5069.93 |
| 52 Week Low | $0.28 | $1.16 |
| 52 Week High | $13.80 | $9.37 |
Technical Indicators
Market Signals| Indicator | ATON | PULM |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 42.60 |
| Support Level | $0.28 | $1.18 |
| Resistance Level | $0.35 | $2.28 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 71.54 | 80.65 |
Price Performance
Historical ComparisonAbout ATON AlphaTON Capital Corp.
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).